Int J Stomatol ›› 2026, Vol. 53 ›› Issue (1): 91-97.doi: 10.7518/gjkq.2026107

• Reviews • Previous Articles     Next Articles

Research progress on cuproptosis in periodontitis

Qiqi Shi(),Xu Qin,Guangxun Zhu()   

  1. Center of Stomatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology & School of Stomatology, Tongji Medical College, Huazhong University of Science and Technology & Hubei Province Key Laboratory of Oral and Maxillofacial Development and Regeneration, Wuhan 430030, China
  • Received:2024-10-12 Revised:2025-07-18 Online:2026-01-01 Published:2025-12-31
  • Contact: Guangxun Zhu E-mail:2657785772@qq.com;zhuguangxun@163.com
  • Supported by:
    National Natural Science Foundation of China(81800981);Natural Science Foundation of Hubei Pro-vince of China(2023AFB653)

Abstract:

Periodontitis is an immune-inflammatory response triggered by periodontal pathogens. In this condition, disrupted immune responses and chronic inflammation play crucial roles in the degradation of periodontal tissues. Cuproptosis, a recently identified form of programmed cell death, is triggered by excessive intracellular copper ions and specifically targets the tricarboxylic acid cycle. It is characterized by the abnormal oligomerization of mitochondrial lipoacylated proteins and the loss of iron-sulfur cluster proteins. Cuproptosis has garnered significant attention for its nonnegligible role in the development and progression of various diseases, including cardiovascular diseases, neurodegenerative disorders, and cancers. Cuproptosis-related genes participate in the pathogenesis of periodontitis by modulating immune cells and cytokines. The abnormal expression of these genes reflects the disease status and aids in clinical diagnosis, providing novel therapeutic targets for periodontitis treatment. Considering these insights, this work presents a comprehensive review of the molecular mechanisms underlying cuproptosis and its role in the initiation and progression of periodontitis.

Key words: cuproptosis, periodontitis, cuproptosis-related genes

CLC Number: 

  • R781.4

TrendMD: 
[1] Tsvetkov P, Coy S, Petrova B, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins[J]. Science, 2022, 375(6586): 1254-1261.
[2] Zhao G, Sun HJ, Zhang T, et al. Copper induce zebrafish retinal developmental defects via triggering stresses and apoptosis[J]. Cell Commun Signal, 2020, 18(1): 45.
[3] Liao JZ, Yang F, Tang ZX, et al. Inhibition of Caspase-1-dependent pyroptosis attenuates copper-induced apoptosis in chicken hepatocytes[J]. Ecotoxicol Environ Saf, 2019, 174: 110-119.
[4] Tao XQ, Wan XL, Wu D, et al. A tandem activation of NLRP3 inflammasome induced by copper oxide nanoparticles and dissolved copper ion in J774A.1 macrophage[J]. J Hazard Mater, 2021, 411: 125134.
[5] Chen LY, Min JX, Wang FD. Copper homeostasis and cuproptosis in health and disease[J]. Signal Transduct Target Ther, 2022, 7: 378.
[6] Li XG, Zhou WB, Zhu C, et al. Multi-omics analysis reveals prognostic and therapeutic value of cuproptosis-related lncRNAs in oral squamous cell carcinoma[J]. Front Genet, 2022, 13: 984911.
[7] Yuan D, Li XQ, Qu FW, et al. Landscape and the immune patterns of cuproptosis in oral squamous cell carcinoma[J]. J Oral Pathol Med, 2023, 52(10): 951-960.
[8] Wei BW, Wang AH, Liu W, et al. Identification of immunological characteristics and cuproptosis-rela-ted molecular clusters in primary Sjögren’s syndrome[J]. Int Immunopharmacol, 2024, 126: 111251.
[9] Oliveri V. Biomedical applications of copper ionophores[J]. Coord Chem Rev, 2020, 422: 213474.
[10] Nagai M, Vo NH, Shin Ogawa L, et al. The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells[J]. Free Radic Biol Med, 2012, 52(10): 2142-2150.
[11] Falls-Hubert KC, Butler AL, Gui K, et al. Disulfiram causes selective hypoxic cancer cell toxicity and radio-chemo-sensitization via redox cycling of copper[J]. Free Radic Biol Med, 2020, 150: 1-11.
[12] Skrott Z, Mistrik M, Andersen KK, et al. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4[J]. Nature, 2017, 552(7684): 194-199.
[13] Zhang JM, Duan DZ, Xu JQ, et al. Redox-dependent copper carrier promotes cellular copper uptake and oxidative stress-mediated apoptosis of cancer cells[J]. ACS Appl Mater Interfaces, 2018, 10(39): 33010-33021.
[14] Ji P, Wang P, Chen H, et al. Potential of copper and copper compounds for anticancer applications[J]. Pharmaceuticals (Basel), 2023, 16(2): 234.
[15] Zulkifli M, Spelbring AN, Zhang YT, et al. FDX1-dependent and independent mechanisms of elesclomol-mediated intracellular copper delivery[J]. Proc Natl Acad Sci U S A, 2023, 120(10): e2216722120.
[16] Braymer JJ, Freibert SA, Rakwalska-Bange M, et al. Mechanistic concepts of iron-sulfur protein biogenesis in Biology[J]. Biochim Biophys Acta Mol Cell Res, 2021, 1868(1): 118863.
[17] Tsvetkov P, Detappe A, Cai K, et al. Mitochondrial metabolism promotes adaptation to proteotoxic stress[J]. Nat Chem Biol, 2019, 15(7): 681-689.
[18] Zhang M, Liu Z, Le Y, et al. Iron-sulfur clusters: a key factor of regulated cell death in cancer[J]. Oxid Med Cell Longev, 2022, 2022: 7449941.
[19] Lill R, Freibert SA. Mechanisms of mitochondrial iron-sulfur protein biogenesis[J]. Annu Rev Biochem, 2020, 89: 471-499.
[20] Yi HS, Chen T, He GT, et al. Retinoic acid mitigates the NSC319726-induced spermatogenesis dysfunction through cuproptosis-independent mechanisms[J]. Cell Biol Toxicol, 2024, 40(1): 26.
[21] Lin CH, Chin Y, Zhou M, et al. Protein lipoylation: mitochondria, cuproptosis, and beyond[J]. Trends Biochem Sci, 2024, 49(8): 729-744.
[22] Dreishpoon MB, Bick NR, Petrova B, et al. FDX1 regulates cellular protein lipoylation through direct binding to LIAS[J]. J Biol Chem, 2023, 299(9): 105046.
[23] Linder MC. Copper homeostasis in mammals, with emphasis on secretion and excretion. a review[J]. Int J Mol Sci, 2020, 21(14): 4932.
[24] Kim H, Wu XB, Lee J. SLC31 (CTR) family of copper transporters in health and disease[J]. Mol Aspects Med, 2013, 34(2/3): 561-570.
[25] Tsang T, Davis CI, Brady DC. Copper biology[J]. Curr Biol, 2021, 31(9): R421-R427.
[26] Xue Q, Kang R, Klionsky DJ, et al. Copper metabolism in cell death and autophagy[J]. Autophagy, 2023, 19(8): 2175-2195.
[27] van den Berghe PVE, Klomp LWJ. Posttranslational regulation of copper transporters[J]. J Biol Inorg Chem, 2010, 15(1): 37-46.
[28] Skopp A, Boyd SD, Ullrich MS, et al. Copper-zinc superoxide dismutase (Sod1) activation terminates interaction between its copper chaperone (Ccs) and the cytosolic metal-binding domain of the copper importer Ctr1[J]. Biometals, 2019, 32(4): 695-705.
[29] Liu SY, Ge JY, Chu YT, et al. Identification of hub cuproptosis related genes and immune cell infiltration characteristics in periodontitis[J]. Front Immunol, 2023, 14: 1164667.
[30] 赵丹丹, 郭子怡, 郭易阳, 等. 基于机器学习和生物信息学分析的铜死亡相关基因在牙周炎中的作用研究[J]. 中华老年口腔医学杂志, 2023, 21(6): 332-336.
Zhao DD, Guo ZY, Guo YY, et al. Role of cuproptosis-related genes in periodontitis based on machine learning and bioinformatics analysis[J]. Chin J Ge-riatr Dent, 2023, 21(6): 332-336.
[31] Liu N, He YQ, Chen XM, et al. Changes in cuproptosis-related gene expression in periodontitis: an integrated bioinformatic analysis[J]. Life Sci, 2024, 338: 122388.
[32] Fu YY, Zhong CB, Cui JH, et al. A comprehensive analysis of the role of cuproptosis in periodontitis through integrated analysis of single-cell and bulk RNA sequencing[J]. Arch Med Sci, 2024, 20(4): 1349-1357.
[33] Ebersole JL, Kirakodu SS, Nguyen LM, et al. Transcriptomic features of programmed and inflammatory cell death in gingival tissues[J]. Oral Dis, 2024, 30(8): 5274-5293.
[34] Zhang LJ, Tsai IC, Ni ZH, et al. Copper chelation therapy attenuates periodontitis inflammation throu-gh the cuproptosis/autophagy/lysosome axis[J]. Int J Mol Sci, 2024, 25(11): 5890.
[35] Maiti BK, Moura I, Moura JJG. Molybdenum-copper antagonism in metalloenzymes and anti-copper therapy[J]. Chembiochem, 2024, 25(6): e202300679.
[36] Hou KL, Lin SK, Kok SH, et al. Increased expression of glutaminase in osteoblasts promotes macrophage recruitment in periapical lesions[J]. J Endod, 2017, 43(4): 602-608.
[37] Yang J, Gao YC, Mao H, et al. Qiju Dihuang Pill protects the lens epithelial cells via alleviating cuproptosis in diabetic cataract[J]. J Ethnopharmacol, 2024, 333: 118444.
[38] Xiao YX, Yin JM, Liu P, et al. Triptolide-induced cuproptosis is a novel antitumor strategy for the treatment of cervical cancer[J]. Cell Mol Biol Lett, 2024, 29(1): 113.
[1] Keer Chen,Jiaqi Bao,Weilian Sun. Application progress of buccal wall morphology affecting alveolar ridge preservation at periodontitis sites [J]. Int J Stomatol, 2026, 53(1): 84-90.
[2] Shiya Wang,Guohua Yuan,Jing Zou. The formation mechanism, clinical diagnosis, and treatment strategies of ectopic enamel [J]. Int J Stomatol, 2025, 52(6): 713-721.
[3] Shuyang Zhang, Shunjiayi Hu, Linlong Qi, Xiaoyao Liang, Shuli Deng. Research progress in regenerative endodontics for traumatized immature permanent teeth [J]. Int J Stomatol, 2025, 52(6): 738-747.
[4] Yuhuang Chen,Xing Liang,Ran Li. Comparison of common restoration methods for missing teeth in patients with periodontitis [J]. Int J Stomatol, 2025, 52(6): 823-831.
[5] Huan Li,Shaozhong Yuan. Research progress on the relationship between periodontitis and non-alcoholic fatty liver disease [J]. Int J Stomatol, 2025, 52(5): 677-683.
[6] Shuyu Zhu,Jing Zhou,Zhigang Xie. Balance between T-helper 17 cells and regulatory T cells in bone remodeling and their impact on oral and maxillofacial damage recovery [J]. Int J Stomatol, 2025, 52(4): 514-525.
[7] Huan Yu,Jian Kang. Progress in the application of periodontal endoscopy in oral clinical diagnosis and treatment [J]. Int J Stomatol, 2025, 52(4): 544-551.
[8] Tianyuan Li, Tongxin Zhu, Qing Liu, Yingchun Dong, Bin Chen. Clinical efficacy of mesenchymal stem cells on periodontal regeneration: a systematic review and meta-analysis [J]. Int J Stomatol, 2025, 52(3): 296-307.
[9] Mengyao Bie,Jieyu Zhou,Yafei Wu,Lei Zhao. Research progress into the effects of Porphyromonas gingivalis on regulatory cell death and phenotypic switching of vascular smooth muscle cells [J]. Int J Stomatol, 2025, 52(3): 308-316.
[10] Xingli Fan,Le Pan,Jiayuan Zhao,Qiumeng Xiang,Qilin Chen. Research progress on the role and mechanism of competitive endogenous RNA in periodontitis [J]. Int J Stomatol, 2025, 52(3): 317-322.
[11] Meilin Zhao,Yiqiong Zhao,Jiao Huang. Treatment of gingival papilla loss with gingival recession in orthodontic patients with stage Ⅲ grade C periodontitis: a case report [J]. Int J Stomatol, 2025, 52(3): 333-340.
[12] Jing Li,Jian Kang. Use of regenerated materials in periodontal minimally invasive surgery [J]. Int J Stomatol, 2025, 52(2): 161-168.
[13] Xiaoyue Zhang,Shuze Chen,Jieyu Zhou,Lei Cheng,Lei Zhao. Studying how Fusobacterium nucleatum affects the intestinal epithelial barrier model in vitro via the ferroptosis pathway [J]. Int J Stomatol, 2025, 52(2): 183-194.
[14] Liangjun Zhong. Application of digital technology in the treatment of advanced periodontitis [J]. Int J Stomatol, 2025, 52(1): 1-10.
[15] Shouzheng Cheng,Taiwen Li,Lei Zhao. Research progress on the correlation between serum amyloid A and periodontitis [J]. Int J Stomatol, 2025, 52(1): 117-122.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!